Pseudotumor of the Larynx: A Previously Unreported Side Effect of Apremilast

Apremilast (Otezla®) is a relatively novel orally administered non-biologic disease-modifying anti-rheumatic drug (DMARD) extensively used in the management of psoriasis and psoriasis arthritis, lately approved for treating oral ulcerations in Behçets disease. Its advantageous side effect profile to...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Eleftherios Ntouniadakis (Auteur), Fredrik Landström (Auteur)
Format: Livre
Publié: Karger Publishers, 2020-12-01T00:00:00Z.
Sujets:
Accès en ligne:Connect to this object online.
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

Connect to this object online.

3rd Floor Main Library

Informations d'exemplaires de 3rd Floor Main Library
Cote: A1234.567
Exemplaire 1 Disponible